Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
Cancer Med. 2020 Aug;9(16):5908-5921. doi: 10.1002/cam4.3287. Epub 2020 Jul 6.
To compare survival outcomes of minimally invasive surgery (MIS) and laparotomy in early-stage cervical cancer (CC) patients.
A multicenter retrospective cohort study was conducted with International Federation of Gynecology and Obstetrics (FIGO, 2009) stage IA1 (lymphovascular invasion)-IIA1 CC patients undergoing MIS or laparotomy at four tertiary hospitals from 2006 to 2017. Propensity score matching and weighting and multivariate Cox regression analyses were performed. Survival was compared in various matched cohorts and subgroups.
Three thousand two hundred and fifty-two patients (2439 MIS and 813 laparotomy) were included after matching. (1) The 2- and 5-year recurrence-free survival (RFS) (2-year, hazard ratio [HR], 1.81;95% confidence interval [CI], 1.09-3.0; 5-year, HR, 2.17; 95% CI, 1.21-3.89) or overall survival (OS) (2-year, HR, 1.87; 95% CI, 1.03-3.40; 5-year, HR, 2.57; 95% CI, 1.29-5.10) were significantly worse for MIS in patients with stage I B1, but not the cohort overall (2-year RFS, HR, 1.04; 95% CI, 0.76-1.42; 2-year OS, HR, 0.99; 95% CI, 0.70-1.41; 5-year RFS, HR, 1.12; 95% CI, 0.76-1.65; 5-year OS, HR, 1.20; 95% CI, 0.79-1.83) or other stages (2) In a subgroup analysis, MIS exhibited poorer survival in many population subsets, even in patients with less risk factors, such as patients with squamous cell carcinoma, negative for parametrial involvement, with negative surgical margins, negative for lymph node metastasis, and deep stromal invasion < 2/3. (3) In the cohort treated with (2172, 54%) or without adjuvant treatment (1814, 46%), MIS showed worse RFS than laparotomy in patients treated without adjuvant treatment, whereas no differences in RFS and OS were observed in adjuvant-treatment cohort. (4) Inadequate surgeon proficiency strongly correlated with poor RFS and OS in patients receiving MIS compared with laparotomy.
MIS exhibited poorer survival outcomes than laparotomy group in many population subsets, even in low-risk subgroups. Therefore, laparotomy should be the recommended approach for CC patients.
比较微创外科(MIS)与剖腹手术治疗早期宫颈癌(CC)患者的生存结局。
采用国际妇产科联盟(FIGO,2009)分期IA1(脉管浸润)-IIA1 CC 患者的多中心回顾性队列研究,在 2006 年至 2017 年间,4 家三级医院对接受 MIS 或剖腹手术的患者进行了研究。采用倾向评分匹配和加权及多变量 Cox 回归分析。在不同匹配队列和亚组中比较生存情况。
匹配后共纳入 3252 例患者(MIS 组 2439 例,剖腹手术组 813 例)。(1)MIS 组患者 2 年和 5 年无复发生存率(RFS)(2 年,风险比[HR],1.81;95%置信区间[CI],1.09-3.0;5 年,HR,2.17;95% CI,1.21-3.89)和总生存(OS)(2 年,HR,1.87;95% CI,1.03-3.40;5 年,HR,2.57;95% CI,1.29-5.10)明显差于剖腹手术组,但在所有患者(2 年 RFS,HR,1.04;95% CI,0.76-1.42;2 年 OS,HR,0.99;95% CI,0.70-1.41;5 年 RFS,HR,1.12;95% CI,0.76-1.65;5 年 OS,HR,1.20;95% CI,0.79-1.83)或其他分期中(2)在亚组分析中,MIS 在许多亚组中表现出较差的生存情况,甚至在风险因素较少的患者中也是如此,如鳞癌、宫旁无浸润、切缘阴性、无淋巴结转移和深间质浸润<2/3。(3)在接受(2172 例,54%)或未接受(1814 例,46%)辅助治疗的患者中,与剖腹手术组相比,MIS 组在未接受辅助治疗的患者中 RFS 较差,而在辅助治疗组中 RFS 和 OS 无差异。(4)与接受剖腹手术的患者相比,手术医生技术不熟练与接受 MIS 治疗的患者 RFS 和 OS 较差密切相关。
MIS 在许多亚组中表现出较差的生存结局,甚至在低危亚组中也是如此。因此,对于 CC 患者,应推荐剖腹手术。